Quality Control Parameters of Crude Drugs

Abstract

Crude drugs derived from plant, animal, and mineral origins constitute the foundational raw materials of traditional medicine systems and occupy a pivotal position in contemporary phytopharmaceutical development. In contrast to chemically synthesized agents — which represent discrete, well-characterized molecular entities — crude drugs comprise intricate biochemical mixtures whose therapeutic properties arise from multi-constituent interactions. The chemical profile, and consequently the efficacy and safety profile, of any crude drug is subject to considerable variation arising from genetic diversity, cultivation geography, harvest timing, post-collection handling, and deliberate or inadvertent adulteration. Such variability renders systematic quality assurance both scientifically indispensable and commercially necessary. Approximately 80% of the global population depends on herbal remedies as the primary avenue of healthcare, underscoring the urgency of rigorous standardization frameworks. This review article systematically examines the multi-tiered quality control parameters applied to crude drugs, encompassing organoleptic and macroscopic characterization, microscopic histological profiling, physicochemical determinations (moisture content, ash values, extractive values, volatile oil content), preliminary and advanced chemical evaluation (chromatographic fingerprinting, spectroscopic methods), and biological safety testing (heavy metal quantification, pesticide residue analysis, mycotoxin screening, microbiological assessment). Special focus is accorded to two exemplary crude drugs — Neem (Azadirachta indica) and Turmeric (Curcuma longa) — as case studies demonstrating the practical application of these parameters. Emerging analytical innovations including DNA barcoding, metabolomics, chemometrics, and portable near-infrared spectroscopy are also discussed as future trajectories in herbal quality management.

Keywords